MedPacto, Inc. announced on March 24th that it has recently appointed global clinical expert and former lead clinician at KaryoPharm, Dr. Timothy R. Allen as the EVP of Clinical Development at MedPacto Therapeutics, a U.S. corporation. Dr. Allen most recently served as Vice President of Clinical Development at KaryoPharm, with a focus on drug development in oncology. In addition to Dr. Allen, MedPacto Therapeutics has recruited Ebla Ali Ibrahim as the Director of Regulatory Affairs (RA) and Cori Greutter as a Senior Clinical Project Manager.

Dr. Allen will be in charge of the clinical strategy and global clinical trials of 'Vactosertib'. In addition, he will be in charge of global clinical development for next-generation candidates after Vactosertib.